Skip to content

Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management

Health Outcomes of Nasopharyngeal Carcinoma Patients Three Years After Treatment by the AI-assisted Home Enteral Nutrition Management

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06603909
Enrollment
500
Registered
2024-09-19
Start date
2021-01-01
Completion date
2024-06-30
Last updated
2024-09-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Artificial Intelligence (AI), Cancer, Carcinoma, Nutrition

Brief summary

You have completed the current stage of cancer treatment, after which you need to check regularly and pay attention to nutrition. So we started this study to see if AI could help with nutrition management. Main options: Option 1: Use AI to assist nutrition management; Option 2: Contact the nutritionist team of the hospital for nutrition management according to your own situation. Option 3: Do not adopt the first two management methods. Special Statement: Please choose; Cancer screening data is used for statistical analysis, but does not reveal any personal privacy.

Interventions

OTHERgroup 1: Use AI to assist nutrition management

group1:AI-assisted nutrition management. group 2:Traditional nutrition management(through the hospital dietitian).group 3:control.

OTHERgroup 2:Traditional nutrition management(through the hospital dietitian)

group 2:Traditional nutrition management(through the hospital dietitian)

Sponsors

Changsha Medical University
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Primary purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Malignant tumor patient

Exclusion criteria

* no

Design outcomes

Primary

MeasureTime frameDescription
Survival Ratethree years after treatmentSurvival Rate
Local Recurrence Ratethree years after treatmentLocal Recurrence Rate

Secondary

MeasureTime frameDescription
DNA positive rate of Epstein-Barr(EB) virusthree years after treatmentDNA positive rate of Epstein-Barr(EB) virus
Body mass indexthree years after treatmentData was obtained through the intelligent body fat device

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026